UNLIMITED TURBO LONG - UCB Share Price

7AKOB

FRBNPP06P0U6

Real-time Euronext Paris 15:25:03 28/05/2024 BST
1.355 ^EUR	-9.36%

Current month	+24.58%
1 month	+22.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	05-23	PU
UCB - Acquisition of own shares	05-20	AQ
UCB : Transparency notification Wellington	05-17	PU
UCB : Acquisition of own shares	05-17	PU

More news

Quotes 5-day view

Date	Price	Change
28/05/24	1.355	-9.36%
27/05/24	1.495	-3.24%
24/05/24	1.545	-6.08%
23/05/24	1.645	+13.84%
22/05/24	1.445	-1.37%

Real-time Euronext Paris

Last update May 28, 2024 at 03:25 pm

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	7AKOB
ISIN	FRBNPP06P0U6
Date issued	15/04/2024
Strike	114.5 €
Maturity	Unlimited
Parity	10 : 1
Emission price	0.48 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.645 €
Lowest since issue	0.455 €
Spread	0.02 €
Spread %	1.44%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

128.2 EUR

Average target price

126.3 EUR

Spread / Average Target

-1.46%

Consensus